Skip Navigation
Jump to Main
Main navigation and Meta Navigation
To Home
Location Navigation
Edition Selection
Singapore Edition
International Edition
Meta Main Navigation
My News Feed
Bookmarks
Watch TV
CNA938 Live
Sign in
User Menu
Profile
My News Feed
My Topics
Bookmarks
Log out
Search
Open
All Sections
All Sections
Close
Section Navigation Title
CNA938
CNA Lifestyle
CNA Insider
Singapore
Asia
World
Business
Sport
Commentary
News Clips
Video on Demand
Podcasts
Open
All Sections
Main Navigation
Section Navigation Title
Home
CNA938
CNA Lifestyle
CNA Insider
Watch TV
CNA938 Live
Singapore Edition
International Edition
Compact Layout
All Sections
Close
Singapore
Asia
World
Business
Sport
Commentary
News Clips
Video on Demand
Podcasts
Singapore Parliament
Weather
PSI
Interactives
Special Reports
Telegram News Service
Facebook
Twitter
LinkedIn
YouTube
RSS
Play Store
App Store
Search results
Close Search
Search Term
Search Term
Clear search input
Search results
AMGEN
close breaking news
AMGEN
Follow
Following
Displaying
10
out of
34
results
World
FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug
The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Pharmacy benefits manager Abarca inks discount deal for Amgen's Enbrel
Abarca, a small Puerto Rico-based pharmacy benefits manager, said on Tuesday Amgen Inc had agreed to give its health insurer clients an additional ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Business
Novartis takes on Sanofi, Amgen with US$9.7 billion takeover of heart drug maker
Novartis AG is buying U.S. biotechnology company The Medicines Co for about US$9.7 billion, the Swiss drugmaker said on Sunday, as it seeks to ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Novartis gets US nod for long-delayed Amgen copycat
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Amgen to take 20.5per cent stake in BeiGene to expand in China
Amgen Inc said on Thursday it will acquire a 20.5per cent stake in BeiGene Ltd in a deal that will enable the California-based biotechnology ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Amgen posts higher biosimilar sales, ends neuroscience program
Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3per cent, but biosimilar sales were strong and the ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Amgen sets one lower list price for its cholesterol drug
Drugmaker Amgen Inc said on Thursday that starting next year, its official list price for cholesterol drug Repatha will be the lower price it ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Low response rate reported for Amgen targeted drug in colon cancer trial
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Amgen drug shrinks lung cancer tumors in half of patients: study
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
World
Patent court to review Alexion's Soliris patents on Amgen challenge: filings
The U.S. patent office will review three patents on Alexion Pharmaceuticals Inc's drug Soliris, after rival Amgen Inc filed a petition challenging ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Explore results
{{pagination.index.feedback}}
1
of
4
NEXT